WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

A PROSPECTIVE AND OBSERVATIONAL STUDY OF CISPLATIN-INDUCED HYPONATREMIA AND ASSESSMENT OF PATIENT'S QUALITY OF LIFE IN PATIENTS UNDERGOING CONCURRENT CHEMORADIATION IN THE ONCOLOGY DEPARTMENT OF TERTIARY CARE HOSPITAL

Bhakti M. Patel*, Alefiya K. Pitolwala*, Sejal V. Vaghela*, Pranshu N. Pareek*, Dr. Anita A. Mehta, Dr. Nirav Asarawala, Dr. Tejal Gandhi and Dr. Akshay Shah

ABSTRACT

Objective: The objective of this study was to investigate and quantify the occurrence, risk factors, and severity of hyponatremia induced by cisplatin, and assessment of the quality of life of cancer patients undergoing concurrent treatment. Method: It was a prospective observational study for evaluating the occurrence of hyponatremia and to assess the Quality of Life of cancer patients receiving cisplatin. The quality of life was assessed by using EORTC QLQ c-30. For QOL the raw scores were computed and linearly transformed to the scale of 0-100. Results: Data from 36 patients were used to assess and evaluate quality of life. All the demographic data was represented as mean and percentage The percentage score for the QOL of patient undergoing chemo radiation was calculate and graph for various domain wasplotted, which conclude that the patient QOL in all the domain was decreased at end of the completion of cisplatin Cycles. Paired t-test was use to find the statistical significance of hyponatremia before and after the treatment of cisplatin chemo-radiation which was (<0.003). The ANOVA test was used to check the within and between-subject variability, there was showed statistical significance. (For QLQ C-30 p-value:

Keywords: Cisplatin, Quality of life, cancer, hyponatremia, QLQ C-30.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More